Skip to main content
Erschienen in: Intensive Care Medicine 9/2013

01.09.2013 | Correspondence

Towards the end of the antibiotic era: let’s save the ancient soldier Colistin!

verfasst von: Alberto Corona, Riccardo Colombo

Erschienen in: Intensive Care Medicine | Ausgabe 9/2013

Einloggen, um Zugang zu erhalten

Excerpt

Dear Editor, …
Literatur
1.
Zurück zum Zitat Oostdijk EA, Smits L, de Smet AM, Leverstein-van Hall MA, Kesecioglu J, Bonten MJ (2013) Colistin resistance in gram-negative bacteria during prophylactic topical colistin use in intensive care units. Intensive Care Med 39(4):653–660PubMedCrossRef Oostdijk EA, Smits L, de Smet AM, Leverstein-van Hall MA, Kesecioglu J, Bonten MJ (2013) Colistin resistance in gram-negative bacteria during prophylactic topical colistin use in intensive care units. Intensive Care Med 39(4):653–660PubMedCrossRef
3.
Zurück zum Zitat Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18(3):268–281PubMedCrossRef Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18(3):268–281PubMedCrossRef
4.
Zurück zum Zitat Nordmann P, Naas T, Poirel L (2011 Oct) Global spread of Carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 17(10):1791–1798PubMedCrossRef Nordmann P, Naas T, Poirel L (2011 Oct) Global spread of Carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 17(10):1791–1798PubMedCrossRef
5.
Zurück zum Zitat Durante-Mangoni E, Signoriello G, Andini R, Mattei A, De Cristoforo M, Murino P, Bassetti M, Malacarne P, Petrosillo N, Galdieri N, Mocavero P, Corcione A, Viscoli C, Zarrilli R, Gallo C, Utili R (2013) Colistin and Rifampicin compared with Colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii. A multicentre, randomised, clinical trial. Clin Infect Dis. doi:10.1093/cid/cit253 PubMed Durante-Mangoni E, Signoriello G, Andini R, Mattei A, De Cristoforo M, Murino P, Bassetti M, Malacarne P, Petrosillo N, Galdieri N, Mocavero P, Corcione A, Viscoli C, Zarrilli R, Gallo C, Utili R (2013) Colistin and Rifampicin compared with Colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii. A multicentre, randomised, clinical trial. Clin Infect Dis. doi:10.​1093/​cid/​cit253 PubMed
Metadaten
Titel
Towards the end of the antibiotic era: let’s save the ancient soldier Colistin!
verfasst von
Alberto Corona
Riccardo Colombo
Publikationsdatum
01.09.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Intensive Care Medicine / Ausgabe 9/2013
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-013-2955-3

Weitere Artikel der Ausgabe 9/2013

Intensive Care Medicine 9/2013 Zur Ausgabe

Imaging in Intensive Care Medicine

Purulent vomica from subdiaphragmatic origin

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.